State of melanoma: an historic overview of a field in transition
- PMID: 24880939
- PMCID: PMC4040458
- DOI: 10.1016/j.hoc.2014.02.010
State of melanoma: an historic overview of a field in transition
Abstract
The last 30 years has seen a revolution in melanoma. Fundamental elements of the surgical, adjuvant medical, and systemic therapy for the disease have been significantly altered toward improved management and better outcomes. The intent of this article is to reflect on past efforts and research in melanoma and the current landscape of treatment of melanoma. The authors also hope to capture the excitement currently rippling through the field and the hope for a cure. The intent of treatment of advanced melanoma, which was once considered incurable, has changed from palliative to potentially curative.
Keywords: Adjuvant; Biology; Combination therapy; Immunotherapy; Melanoma; Neoadjuvant; Prognosis; Targeted therapies.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
[Melanoma update].Rev Med Interne. 2019 Mar;40(3):178-183. doi: 10.1016/j.revmed.2018.11.005. Epub 2018 Dec 6. Rev Med Interne. 2019. PMID: 30527396 Review. French.
-
Recent advances in malignant melanoma.Intern Med J. 2017 Oct;47(10):1114-1121. doi: 10.1111/imj.13574. Intern Med J. 2017. PMID: 28994264 Review.
-
State of Melanoma: An Historic Overview of a Field in Transition.Hematol Oncol Clin North Am. 2021 Feb;35(1):1-27. doi: 10.1016/j.hoc.2020.09.003. Epub 2020 Oct 26. Hematol Oncol Clin North Am. 2021. PMID: 33759768 Review.
-
Indications and options for systemic therapy in melanoma.Surg Clin North Am. 2014 Oct;94(5):1049-58, viii. doi: 10.1016/j.suc.2014.07.007. Epub 2014 Aug 6. Surg Clin North Am. 2014. PMID: 25245967 Review.
-
[Advances in immunotherapy for metastatic melanoma].Magy Onkol. 2017 Jun 6;61(2):132-136. Epub 2017 May 10. Magy Onkol. 2017. PMID: 28585614 Review. Hungarian.
Cited by
-
Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells.J Vet Med Sci. 2023 Sep 7;85(9):977-984. doi: 10.1292/jvms.23-0274. Epub 2023 Aug 11. J Vet Med Sci. 2023. PMID: 37495516 Free PMC article.
-
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.Int J Mol Sci. 2022 Aug 15;23(16):9124. doi: 10.3390/ijms23169124. Int J Mol Sci. 2022. PMID: 36012390 Free PMC article.
-
Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma.Cancers (Basel). 2021 Jun 9;13(12):2875. doi: 10.3390/cancers13122875. Cancers (Basel). 2021. PMID: 34207514 Free PMC article. Review.
-
Evaluation of In Vitro Antioxidant and Anticancer Properties of the Aqueous Extract from the Stem Bark of Stryphnodendron adstringens.Int J Mol Sci. 2018 Aug 17;19(8):2432. doi: 10.3390/ijms19082432. Int J Mol Sci. 2018. PMID: 30126115 Free PMC article.
-
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.Cancer Immunol Immunother. 2020 Nov;69(11):2319-2331. doi: 10.1007/s00262-020-02626-4. Epub 2020 Jun 7. Cancer Immunol Immunother. 2020. PMID: 32507967 Free PMC article.
References
-
- Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Miller AJ, Mihm MC., Jr Melanoma. N Engl J Med. 2006;355:51–65. - PubMed
-
- Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) National Cancer Institute; Bethesda, MD: 2012. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
-
- WHO. Skin cancers. 2013.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous